Sato, K., Yanagisawa, M., Hashizume, H., Yamazaki, Y., Horiguchi, N., Kakizaki, S., & Mori, M. (2013). Extended therapy duration for therapy-refractory hepatitis C patients with genotype 2. Baishideng Publishing Group Co., Limited.
Chicago Stili AlıntıSato, Ken, Masatoshi Yanagisawa, Hiroaki Hashizume, Yuichi Yamazaki, Norio Horiguchi, Satoru Kakizaki, ve Masatomo Mori. Extended Therapy Duration for Therapy-refractory Hepatitis C Patients With Genotype 2. Baishideng Publishing Group Co., Limited, 2013.
MLA AlıntıSato, Ken, et al. Extended Therapy Duration for Therapy-refractory Hepatitis C Patients With Genotype 2. Baishideng Publishing Group Co., Limited, 2013.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..